Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Mark-Alexander Schwarzbich"'
Autor:
Mark-Alexander Schwarzbich, Hao Dai, Lambros Kordelas, Dietrich W. Beelen, Aleksandar Radujkovic, Carsten Müller-Tidow, Peter Dreger, Thomas Luft
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 4, p 2337 (2022)
Weight loss and metabolic activity influence outcome after allogeneic stem cell transplantation (alloSCT). This study evaluates pre-conditioning Leptin, a peptide hormone involved in metabolism and immune homeostasis, as a prognostic factor for survi
Externí odkaz:
https://doaj.org/article/29944e7d68cd48159309e8c5524f93bd
Autor:
Thomas Luft, Carsten Müller-Tidow, Manuela Hummel, Axel Benner, Aleksandar Radujkovic, Mark-Alexander Schwarzbich, Peter Dreger, Katharina Dischinger, Nicola Giesen, Natalia Becker
Publikováno v:
Transplantation. 104:2354-2359
BACKGROUND Chronic graft-versus-host disease (cGVHD) represents a double-edged sword. In its nonsevere form, cGVHD associates with better control of the malignant disease, thus highlighting graft-versus-leukemia effects. However, severe cGVHD leads t
Publikováno v:
Handbook of Cancer and Immunology ISBN: 9783030809621
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5a2310136a7e8d425333ab836fe5a31
https://doi.org/10.1007/978-3-030-80962-1_178-1
https://doi.org/10.1007/978-3-030-80962-1_178-1
Publikováno v:
Oncology Research and Treatment. 40:674-681
In recent years, cellular immunotherapy in B-cell malignancies has been driven by adoptive transfer of genetically engineered T cells expressing chimeric antigen receptors (CARs). CARs consist of a single chain variable fragment (scFv) of a monoclona
Autor:
Mark Kriegsmann, Katharina Lisenko, Patrick Wuchter, Mathias Witzens-Harig, Martin Cremer, Mark-Alexander Schwarzbich, Anthony D. Ho
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:1397-1402
In patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL), R-DHAP (rituximab, dexamethasone, cytarabine, and cisplatin) is a commonly used regimen for salvage therapy and for mobilization of peripheral blood stem cells (PBSCs). At
Autor:
Mark-Alexander Schwarzbich, Anthony D. Ho, Katharina Lisenko, Tilman Schöning, Martin Cremer, Matthias Witzens-Harig
Publikováno v:
Leukemia & Lymphoma. 57:1723-1726
Standard treatment for diffuse large cell lymphoma (DLBCL) with rituximab cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) is curative in the majority of patients with low risk di...
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 212
Abnormal B-cell receptor (BCR) signalling is a key mechanism of disease progression in B-cell malignancy. Bruton's tyrosine kinase (BTK) has a pivotal role in BCR signalling. Ibrutinib (PCI-32765) is a small molecule which serves as a covalent irreve
Autor:
Mark Kriegsmann, Mathias Witzens-Harig, Manfred Hensel, Patrick Wuchter, Anthony D. Ho, Mark-Alexander Schwarzbich, Thomas Bruckner, Katharina Kriegsmann, Sören Sitter, Michael A. Rieger
Publikováno v:
European journal of haematology. 101(1)
Objective For more than two decades, high-dose chemotherapy (HDT) and autologous blood stem cell transplantation (ABSCT) were treatment options for patients with aggressive B-cell non-Hodgkin's lymphoma (B-NHL). However, the ideal timing and the coll
Publikováno v:
Small Molecules in Hematology ISBN: 9783319914381
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::123b249335f28ffba61a632277a7efb9
https://doi.org/10.1007/978-3-319-91439-8_7
https://doi.org/10.1007/978-3-319-91439-8_7
Autor:
Mark-Alexander Schwarzbich, Mathias Witzens-Harig, Anthony D. Ho, Martin Cremer, Katharina Lisenko, Tilman Schöning
Publikováno v:
Annals of hematology. 96(9)